Skip to main content
JIN YANG PHARMACEUTICAL. CO., LTD logo

JIN YANG PHARMACEUTICAL. CO., LTD — Investor Relations & Filings

Ticker · 007370 ISIN · KR7007370000 KO Manufacturing
Open in API
Filings indexed 210 across all filing types
Latest filing 2026-02-04 Management Reports
Country KR South Korea
Listing KO 007370

About JIN YANG PHARMACEUTICAL. CO., LTD

https://www.jinyangpharm.com/

JIN YANG PHARMACEUTICAL. CO., LTD. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products, with a primary focus on prescription drugs. The company operates a fully automated, high-tech manufacturing facility. Its research and development efforts are dedicated to creating advanced preventive and therapeutic treatments for various diseases. Key areas of R&D include the development of anticancer drugs through molecular biology research, particularly for leukemia, and therapies for metabolic disorders such as diabetes and obesity. The company also develops antivirals and explores formulations based on herbal preparations.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Jinyang Pharmaceutical) announcing a significant change in financial results (revenue or profit/loss structure exceeding 15% for large corporations or 30% for others). This is a standard disclosure requirement in the Korean stock market (KRX) for preliminary financial results before the final audit report is published. Since it provides key financial highlights (revenue, operating profit, net income) for the fiscal year, it fits the definition of an Earnings Release (ER).
2026-02-04 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Jinyang Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the approval process. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2025-12-24 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Jinyang Pharmaceutical regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the 48th Annual General Meeting. It is a standard corporate disclosure regarding shareholder rights and meeting preparation, which falls under general regulatory announcements.
2025-12-16 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 98% confidence The document is a regulatory announcement from Jinyang Pharmaceutical regarding the setting of a record date for shareholder register closure for the purpose of dividend distribution. While it mentions dividends, it is not the final declaration of the dividend amount (DIV), but rather a procedural notice regarding the record date for the upcoming AGM. Given the nature of the announcement as a regulatory disclosure of corporate action, it fits best under the general regulatory filing category.
2025-12-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서(약식)' which translates to 'Report on Large Shareholding Status (Abbreviated)'. It details the shareholding status of a significant shareholder, including the number of shares held, changes due to convertible bond acquisition, and related information. The document references legal provisions related to large shareholding disclosures and includes detailed tables about share ownership and changes. This matches the description of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds. The document is about reporting large shareholding status, not an annual report, earnings release, or other types of filings. Therefore, the correct classification is Major Shareholding Notification (MRQ). The document length is sufficient and contains detailed data, not just an announcement or certification, so it is not RNS or RPA.
2025-10-16 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '임시주주총회결과' which translates to 'Extraordinary General Meeting (EGM) Results'. It details the resolutions passed at the meeting, including the appointment of two inside directors and amendments to the articles of incorporation. The document includes the date of the meeting (2025-10-02) and references related prior announcements. The content is a formal announcement of voting results from a shareholder meeting, not the meeting materials or a full report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1410 characters), consistent with a voting result announcement rather than a full report or presentation.
2025-10-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.